Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to confirm if myocardial protection effect can be obtained by intravenous administration of glutamine in patients undergoing aortic valve replacement with severe aortic stenosis (who are at high risk for ischemia-reperfusion injury). As a prospective double blinded randomized placebo-controlled trial, the investigators detect and compare the degree of myocardial damage(with CK-MB and Troponin T) and myocardial protection (through hsp 70 expression in atrial tissue), cardiovascular index, inflammatory reaction, and clinical manifestation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03341169
Study type Interventional
Source Yonsei University
Contact Jong Wook Song, MD
Phone 82-2-2227-3971
Email SJW72331@yuhs.ac
Status Recruiting
Phase N/A
Start date March 20, 2018
Completion date September 28, 2019